| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |